Stock listing
NASDAQ:ITMN InterMune Inc Stock
Follow InterMune Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ITMN
$73.89 USD
Close on Sep 26, 2014 · No longer trades
- Lowest – highest close
- $7.24 – $73.91 USDSince Mar 24, 2000 · lowest Aug 20, 2012 · highest Sep 25, 2014
Delisted NASDAQ:ITMN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ITMN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
InterMune Inc on 6ix
- Decks
- 4 decks · latest Jun 4, 2014
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2014) | Investor deck | 40 slides | Jun 4, 2014 |
| Technical Presentation (February 2014) | Technical | 25 slides | Feb 25, 2014 |
| J.P. Morgan 2014 Healthcare Conference | Conference | 29 slides | Jan 13, 2014 |
| J.P. Morgan 31st Annual Healthcare Conference 2013 | Conference | 27 slides | Jan 7, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| William R Ringo Other companies: Assembly Biosciences, Inc. (Director · Since at least Jul 10, 2014); Sensei Biotherapeutics, Inc. (Director · Mar 8, 2022 – May 21, 2025 · Past); Five Prime Therapeutics Inc (Director · Oct 1, 2014 – Apr 5, 2021 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Onyx Pharmaceuticals Inc (Director · Feb 3, 2011 – Oct 1, 2013 · Past); Sangamo Therapeutics, Inc. (Director · Apr 16, 2010 – Sep 20, 2017 · Past); Pfizer, Inc. (Senior Vice President · Apr 1, 2008 – Mar 31, 2010 · Past); Allos Therapeutics Inc (Director · Jan 5, 2007 – Jun 19, 2007 · Past); Inspire Pharmaceuticals Inc (Director · Jun 13, 2006 – Jun 8, 2007 · Past); Abgenix Inc (CEO and President, Director · Apr 1, 2006 – Apr 1, 2006 · Past) | Director · Feb 23, 2006 – May 15, 2007 · Past |
| Daniel G. Welch Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past) | Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past |
| Jonathan Leff Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); AveXis Inc (Director · Feb 10, 2016 – Feb 10, 2016 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past) | EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past |
| Lars G. Ekman Other companies: Prothena Corporation plc (Chair Emeritus · Since at least Dec 20, 2012); Ultragenyx Pharmaceutical Inc. (Director · Mar 17, 2016 – Jun 24, 2022 · Past); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Ocera Therapeutics Inc (Director · Jul 15, 2013 – Jun 11, 2014 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Jun 27, 2022 · Past); Aryx Therapeutics Inc (Director · Apr 30, 2010 – Apr 30, 2010 · Past) | Director · May 10, 2010 – Sep 29, 2014 · Past |
| Paul D Arata | EVP, Human Resources & Admin · Jul 16, 2012 – Sep 29, 2014 · Past |
| Williamson Z Bradford III | SVP-Clinical Science · Jan 16, 2006 – May 11, 2012 · Past |
Log in to ask 6ix AI your own questions about InterMune Inc.